Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs

BACKGROUND: We investigated the incidence of chronic kidney disease (CKD) progression and its factors relevant to patients with stable rheumatoid arthritis (RA). METHODS: We enrolled consecutive patients with RA who had initiated treatment with a biologic disease-modifying anti-rheumatic drug (bDMAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanaoka, Hironari, Kikuchi, Jun, Hiramoto, Kazuoto, Saito, Shuntaro, Kondo, Yasushi, Kaneko, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217658/
https://www.ncbi.nlm.nih.gov/pubmed/35756739
http://dx.doi.org/10.1093/ckj/sfac036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217658/
https://www.ncbi.nlm.nih.gov/pubmed/35756739
http://dx.doi.org/10.1093/ckj/sfac036

Ejemplares similares